Jazz Pharmaceuticals (JAZZ) Times Interest Earned (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Times Interest Earned of $0.58 for Q1 2026, up 756.44% year-over-year from $0.07 in Q1 2025, and down 92.85% quarter-over-quarter from $8.13 in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Times Interest Earned (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Times Interest Earned history runs 17 years deep, the most recent figure standing at $0.58 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 756.44% year-over-year to $0.58; the TTM figure through Mar 2026 stood at -$0.07 (down 106.92% YoY), while the FY2025 annual figure was -$0.66, down 147.23% from the prior year.
- Times Interest Earned for Q1 2026 stood at $0.58, down from $8.13 in the prior quarter.
- The five-year high for Times Interest Earned was $23.19 in Q2 2024, with the low at -$10.45 in Q4 2022.
- The 5-year median for Times Interest Earned is $0.21 (2023), against an average of $1.35.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned slumped 622.8% in 2022, then surged 8976.91% in 2024.
- Jazz Pharmaceuticals' Times Interest Earned stood at -$10.45 in 2022, then soared by 103.71% to $0.39 in 2023, then surged by 57.62% to $0.61 in 2024, then surged by 1232.21% to $8.13 in 2025, then tumbled by 92.85% to $0.58 in 2026.
- Business Quant data shows JAZZ's Times Interest Earned at $0.58 in Q1 2026, $8.13 in Q4 2025, and $0.09 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 0.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.43 |
| Mar 31, 2026 | 0.58 |
| Dec 31, 2025 | 8.13 |
| Sep 30, 2025 | 0.09 |
| Jun 30, 2025 | -1.06 |
| Mar 31, 2025 | -0.09 |
| Dec 31, 2024 | 0.61 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | 23.19 |
| Mar 31, 2024 | 0.11 |
| Dec 31, 2023 | 0.39 |
| Sep 30, 2023 | 0.29 |
| Jun 30, 2023 | 0.26 |
| Mar 31, 2023 | 0.21 |
| Dec 31, 2022 | -10.45 |
| Sep 30, 2022 | 0.05 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.14 |
| Dec 31, 2021 | 2.00 |
| Sep 30, 2021 | 0.05 |